Literature DB >> 6482627

Modified tracheoesophageal diversion for chronic aspiration.

Y P Krespi, V C Quatela, G A Sisson, M L Som.   

Abstract

Breakdown of the normal protective function of the larynx, either through primary laryngologic or neurologic causes, leads to chronic aspiration, recurrent pneumonitis and possibly death. In this paper we discuss the existing surgical treatments for chronic aspiration. Tracheal separation and trecheoesophageal diversion are discussed, as are the difficulties of using these procedures in patients with pre-existing tracheostomies. A modification of tracheoesophageal diversion is presented whereby this procedure can now be utilized in those patients with pre-existing tracheostomies. The modified tracheoesophageal diversion is performed in five patients successfully. Since most patients have already had tracheotomies in an attempt to control aspiration, we feel that our technique of modified tracheoesophageal diversion enables this group of patients to benefit from this procedure as well.

Entities:  

Mesh:

Year:  1984        PMID: 6482627     DOI: 10.1288/00005537-198410000-00007

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

Review 1.  Surgical approaches to aspiration.

Authors:  D W Eisele
Journal:  Dysphagia       Date:  1991       Impact factor: 3.438

Review 2.  Approaches to the patient with aspiration and swallowing disabilities.

Authors:  A Blitzer
Journal:  Dysphagia       Date:  1990       Impact factor: 3.438

3.  Tracheocutaneous fistula as a complication of laryngotracheal separation surgery.

Authors:  Orlando B Zocratto; Keli B F Zocratto; Ana Y Y Mao; Geovane S Oliveira; Luiza Ferreira
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-03       Impact factor: 2.503

4.  Drainage of the tracheal blind pouch created by laryngotracheal separation.

Authors:  Hideaki Suzuki; Nobuaki Hiraki; Chie Murakami; Seiko Suzuki; Akiko Takada; Toyoaki Ohbuchi; Minori Shibata; Koichi Hashida; Masayuki Shimono
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-13       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.